ADD TO CART

Tirzepatide

Tirzepatide is a research compound supplied as a lyophilised (freeze-dried) vial for laboratory research and educational use only. The product image shows a 10mg vial at 99.6% purity.


Reported areas of research interest: Tirzepatide is described as a dual-agonist research compound active across the GLP-1 and GIP receptor pathways (incretin pathways). In preclinical (non-human) studies, compounds in this class have been investigated for reported roles in glucose-regulation, metabolic and body-weight research models. These represent areas of ongoing scientific investigation only.


DRAFT LISTING: please verify your own label, COA, strength, storage instructions and fulfilment details before publishing. Bacteriostatic water and accessories are sold separately. For research purposes only — not for human or animal consumption, or for clinical, diagnostic or therapeutic use.

£50.00

  • SPECIFICATIONS

    Type: Dual-agonist research compound (GLP-1 / GIP pathways)

    Size (per image): 10mg

    Purity (per image): 99.6%

    Form: Lyophilised (freeze-dried) vial

    Note: Draft listing - confirm your own purity, testing and storage data before going live.

  • HOW TO USE

    Storage: Confirm storage instructions against your own supplier guidance before publishing. General research peptide guidance: store lyophilised material at -20°C, away from UV light; once reconstituted, store at 2°C–6°C, away from UV light.

    Reconstitution: Bacteriostatic water and accessories are sold separately.

    For research purposes only. Not for human or animal consumption, or for clinical, diagnostic or therapeutic use.

BESTSELLERS

You may also like